Regulatory Science and Policy

• 1392 · PDF A mixed-methods evaluation of multilevel barriers and facilitators to inform implementation strategies for advancing equitable clinical trial accrual in a large comprehensive cancer center Morgan Gill, Syma Iqbal, Vibha Kodancha, Emmeline Friedman, Diana L. Hanna, Chanita Hughes-Halbert, Anthony El-Khoueiry, Jennifer Tsui
• 1393 · PDF Design of a prospective implementation study to evaluate the efficacy of an AI-assisted workflow intervention to increase breast cancer clinical trial participation Jacob T. Rosenthal, Emma Hahesy, Sulov Chalise, Zhigang Zhang, Menglei Zhu, Mert R. Sabuncu, Anyi Li, Lior Zvi Braunstein
• 1394 · PDF Effect of biopsy requirement on patient enrollment to phase I trials in cancer Catherine Yang, Mona Yuan, Sebastian Saenz, Marisa Palmeri, Mohammad Ghalib, Dina Oz, Diana Nelson, Rita M. Musanti, Devika Rao, Eugenia Girda, Francis Kang, Sanjay Goel
• 1395 · PDF The distribution of non-small cell lung cancer early phase clinical trial sites within and outside the United States Brittany Avin McKelvey, Luke Saxton-Stivers, Tod Guidry, Andrea E. Ferris
• 1396 · PDF Streamlining combined clinical trial and diagnostic device development: The EMA COMBINE Project Pilot Louis-Guillaume Marquier
• 1397 · PDF Genomic Relational Privacy in AI Era: a scoping review Ying Huang, Emily Boja, Jaime Guidry Auvil
• 1398 · PDF Thematic trends in cancer research from sub-Saharan Africa: Insights from a five-year institutional dataset Adedayo Joseph, Funmilayo Aina-Tolofari, Ayodeji O. Ojetunde, Philip Ejeikwu, Lilian Ekpo, Tolulope Adewole
• 1399 Analysis of regulatory and scientific activities of SFDA oncology and hematology section in sixteen months Tariq Hassan AL Qurayshah, SFDA Oncology & Hematology Group
• 1400 · PDF Addressing the EU IVDR challenge in targeted oncology trials Margaret Curnutte
• 1401 · PDF A novel statistical framework for surrogate endpoint prediction of survival in neoadjuvant breast cancer trials Keli S. Santos-Parker, Jessica R. Santos-Parker, W. Fraser Symmans, Laura J. Esserman, Christina Yau, Angie DeMichele, Laura van't Veer, Doug Yee, Fabien Reyal, Helena Earl, Jean Abraham, David Cameron, Peter Hall, Judy Boughey, Matthew Goetz, Gabe Sonke, Miguel Martín, Sara López-Tarruella, Priyanka Sharma, Rachel Freiberg, Jane Perlmutter, Aditya Bardia, Martin Eklund, Rachel Freiberg, Lajos Pusztai
• 1402 · PDF Real world clinical outcomes with trastuzumab deruxtecan in HER2 expressing ovarian and endometrial cancer Oladunni Alomaja, Jordyn F. Silverstein, Maryam Hajiabbasi, Eliya Shachar, Shivani Thaker, Beth Karlan, Aditya Bardia, Gottfried E. Konecny, First two authors contributed equally and share first authorship

在完整检索应用中浏览本分会场 →